Skip to content

Intraoperative Propofol and Dexmedetomidine on Peripheral Inflammation Induced by Hip or Knee Arthroplasty

Intraoperative Propofol and Dexmedetomidine on Peripheral Inflammation Induced by Hip or Knee Arthroplasty

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900020480
Enrollment
Unknown
Registered
2019-01-01
Start date
2019-01-10
Completion date
Unknown
Last updated
2019-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Group 1:sedated by dexmedetomidine
Group 2:sedated by dexmedetomidine

Sponsors

Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: Aged at least 65 years; undergoing total hip or knee arthroplasty, and be classified as American Society of Anesthesiologists (ASA) physical health class I–IV.

Exclusion criteria

Exclusion criteria: Contraindications to spinal anesthesia (i.e., coagulopathy, concurrent use of anticoagulants, infection at puncture site, and refusal of spinal anesthesia), patients with infectious diseases, patients with mental or language barriers, patients who had been anesthetized within the past 30 days, severe congestive heart failure (New York Heart Association, class IV) and/or severe chronic obstructive pulmonary disease (Global Initiative for Chronic Obstructive Lung Disease Guidelines, stages III–IV), sick sinus syndrome, severe sinus bradycardia (< 50 beats per min), and second or greater atrioventricular block without pacemaker. In addition, patients(MMSE) score < 24) and/or preoperative delirium (i.e., positive Confusion Assessment Method (CAM) result) were excluded. exhibiting cognitive impairment (i.e., a Mini-Mental State Examination (MMSE) score < 24) and/or preoperative delirium (i.e., positive Confusion Assessment Method (CAM) result) were excluded.

Design outcomes

Primary

MeasureTime frame
Change of the concentration of plasma IL-6 from baseline to the end surgery;

Secondary

MeasureTime frame
The incidence of postoperative delirium;The incidence of postoperative cognitive dysfunction;Change of the concentration of plasma TNF-a from baseline to the end surgery;

Countries

China

Contacts

Public ContactXuesheng Liu

Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University

liuxuesheng@ahmu.edu.cn+86 551 62922057

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026